• Latest

CDMOs to benefit from rising BTDs, orphan drugs and fast track status

The arrival of patient-centric CDMO's predicted by CPhI Annual Report  Frankfurt, November 13, 2019: CPhI Worldwide – the world's largest pharma…

• Latest

Piramal Pharma Solutions recognized by Frost & Sullivan for its End-to-End Integrated Services Across the Entire Drug Development Life Cycle

~ Creating seamless transitioning of products for customers to optimize customers' production economies, simplify developmental complexity, and improve time-to-market of new…

• Investment

Piramal Pharma Solutions Invests $10 million USD to Expand its High Potency API Capability in its Riverview Facility in U.S.

~ Expansion enhances the company’s ability to serve the growing ADC market ~  Michigan, June 21, 2019: Piramal Pharma Solutions (PPS),…

• Extras

Piramal Pharma Solutions Unveils its New cGMP Kilo Lab Suite for Active Pharmaceutical Ingredient (API) at Ennore, Chennai

Chennai, November 22, 2018: Piramal Pharma Solutions (PPS), a leading Contract Development and Manufacturing Organization (CDMO) announced the completion of…

Piramal Pharma Solutions launches of Xcelerate Integrated Solutions™

Lexington, November 11, 2018:: Piramal Pharma Solutions (PPS), a global leader in Contract Development and Manufacturing Solutions, announced the launch…

Piramal Pharma Solutions Announces the Launch of Xcelerate Integrated Solutions™

Lexington, November 11, 2018: Piramal Pharma Solutions (PPS), a global leader in Contract Development and Manufacturing Solutions, announced the launch of…